LPL Financial’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-108,865
| Closed | -$96.5K | – | 4622 |
|
2022
Q4 | $96.5K | Sell |
108,865
-5,238
| -5% | -$4.64K | ﹤0.01% | 4149 |
|
2022
Q3 | $179K | Sell |
114,103
-2,447
| -2% | -$3.84K | ﹤0.01% | 3948 |
|
2022
Q2 | $234K | Buy |
116,550
+8,146
| +8% | +$16.4K | ﹤0.01% | 3797 |
|
2022
Q1 | $253K | Buy |
108,404
+23,871
| +28% | +$55.7K | ﹤0.01% | 3684 |
|
2021
Q4 | $393K | Sell |
84,533
-27,200
| -24% | -$126K | ﹤0.01% | 3472 |
|
2021
Q3 | $853K | Sell |
111,733
-2,578
| -2% | -$19.7K | ﹤0.01% | 2735 |
|
2021
Q2 | $1.11M | Buy |
114,311
+14,167
| +14% | +$137K | ﹤0.01% | 2472 |
|
2021
Q1 | $828K | Sell |
100,144
-79,603
| -44% | -$658K | ﹤0.01% | 2556 |
|
2020
Q4 | $1.23M | Buy |
179,747
+7,771
| +5% | +$53K | ﹤0.01% | 2024 |
|
2020
Q3 | $1.92M | Sell |
171,976
-109,070
| -39% | -$1.22M | ﹤0.01% | 1478 |
|
2020
Q2 | $1.77M | Buy |
281,046
+265,436
| +1,700% | +$1.67M | ﹤0.01% | 1420 |
|
2020
Q1 | $29K | Buy |
+15,610
| New | +$29K | ﹤0.01% | 3115 |
|